Diclofenac injection - Hospira

Drug Profile

Diclofenac injection - Hospira

Alternative Names: Dyloject

Latest Information Update: 07 Feb 2017

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Javelin Pharmaceuticals
  • Developer Hospira; Javelin Pharmaceuticals
  • Class Antipyretics; Antirheumatics; Non-opioid analgesics; Nonsteroidal anti-inflammatories; Phenylacetates; Small molecules
  • Mechanism of Action Cyclooxygenase inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Marketed Postoperative pain

Most Recent Events

  • 18 Jun 2015 Launched for Postoperative pain in USA (IV) before June 2015
  • 30 Dec 2014 Registered for Postoperative pain in USA (IV)
  • 31 Dec 2013 Hospira receives a second complete response letter from the US FDA for injectable diclofenac in Postoperative pain
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top